Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi G, Anderloni A, Bianchi Porro G
Department of Gastroenterology, L. Sacco University Hospital, Milan, Italy.
Aliment Pharmacol Ther. 2002 Mar;16(3):553-7. doi: 10.1046/j.1365-2036.2002.01192.x.
Proton pump inhibitors may interfere with the accuracy of the (13)C-urea breath test, but little information is available on the effect of standard doses of various proton pump inhibitors on this test.
To evaluate the effect of short-term standard doses of omeprazole, lansoprazole and pantoprazole on the accuracy of the standardized (13)C-urea breath test.
A total of 124 patients with Helicobacter pylori infection, diagnosed on the basis of gastric histology, rapid urease test and (13)C-urea breath test, were studied. These patients received omeprazole, 20 mg/day, lansoprazole, 30 mg/day, or pantoprazole, 40 mg/day, for 2 weeks according to a randomized protocol. (13)C-Urea breath test was repeated on days 4, 7 and 14 while on therapy and 7 days after proton pump inhibitor withdrawal.
Of the patients receiving omeprazole and lansoprazole, 30% (12/40) and 20% (8/41), respectively, became (13)C-urea breath test negative during therapy, compared with none of the 42 patients treated with pantoprazole (P < 0.05). All the false negative (13)C-urea breath test results returned to positive within 1 week of drug withdrawal, with a mean recovery to 84.7 +/- 15.6% of baseline delta(13)CO(2).
Short-term omeprazole and lansoprazole interfere with the 13C-urea breath test, although a return to positive test results invariably occurs within 1 week of proton pump inhibitor withdrawal. In contrast, the accuracy of the (13)C-urea breath test does not appear to be significantly impaired by short-term pantoprazole, which therefore may not necessarily be withdrawn before this test.
质子泵抑制剂可能会干扰(13)C-尿素呼气试验的准确性,但关于各种质子泵抑制剂标准剂量对该试验的影响,目前所知甚少。
评估短期标准剂量的奥美拉唑、兰索拉唑和泮托拉唑对标准化(13)C-尿素呼气试验准确性的影响。
共研究了124例经胃组织学、快速尿素酶试验和(13)C-尿素呼气试验确诊的幽门螺杆菌感染患者。这些患者按照随机方案接受2周的治疗,其中奥美拉唑20毫克/天、兰索拉唑30毫克/天或泮托拉唑40毫克/天。在治疗的第4、7和14天以及质子泵抑制剂停药后7天重复进行(13)C-尿素呼气试验。
接受奥美拉唑和兰索拉唑治疗的患者中,分别有30%(12/40)和20%(8/41)在治疗期间(13)C-尿素呼气试验转为阴性,而接受泮托拉唑治疗的42例患者中无一例出现这种情况(P<0.05)。所有假阴性的(13)C-尿素呼气试验结果在停药后1周内均恢复为阳性,平均恢复至基线δ(13)CO₂的84.7±15.6%。
短期使用奥美拉唑和兰索拉唑会干扰(13)C-尿素呼气试验,尽管在质子泵抑制剂停药后1周内试验结果总会恢复为阳性。相比之下,短期使用泮托拉唑似乎不会显著损害(13)C-尿素呼气试验的准确性,因此在进行该试验前不一定需要停用泮托拉唑。